3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Head and Neck Neoplasms
3
Nasopharyngeal Carcinoma
2
Squamous Cell Carcinoma of Head and Neck
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hypopharyngeal Neoplasms
1
Hematologic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Advanced Gastric Cancer
1
Adenocarcinoma of Lung
1
Interventions
apatinib
8
Paclitaxel
7
Capecitabine
7
Oxaliplatin
6
Cisplatin
5
camrelizumab
4
S 1 (combination)
3
Fluorouracil
3
130-nm albumin-bound paclitaxel
3
Leucovorin
2
Drug Therapy
2
Docetaxel
2
trifluridine tipiracil drug combination
1
titanium silicide
1
tipiracil
1
raltitrexed
1
pazopanib
1
olaparib
1
lobaplatin
1
ezogabine
1
endostar protein
1
durvalumab
1
dacomitinib
1
capivasertib
1
Trifluridine
1
Sunitinib
1
SHR-1701
1
Ramucirumab
1
Metabolic Networks and Pathways
1
Irinotecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Advanced Gastric Cancer
×
CF regimen
×
Clear all
NCT00992199
2010-09-08
IPchemo-AGC
Fudan University
Phase 2
Unknown
79 enrolled